Developmental origins of type 2 diabetes: A perspective from China

European Journal of Clinical Nutrition

Volumn 71, Issue 7, 2017, Pages 870-880

  Ma, R C W ^a,b   Tsoi, K Y ^a   Tam, W H ^a   Wong, C K C ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF SYDNEY   (Australia)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINE DISRUPTOR;

BREAST FEEDING; CHILD NUTRITION; CHILDHOOD OBESITY; CHINA; DRINKING BEHAVIOR; EPIDEMIC; EPIGENETICS; EXPOSURE; GENETIC REGULATION; GESTATIONAL WEIGHT GAIN; HUMAN; HYPERGLYCEMIA; INTESTINE FLORA; LIFESTYLE; MALNUTRITION; MATERNAL NUTRITION; MATERNAL OBESITY; MATERNAL SMOKING; MATERNAL STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREGNANCY DIABETES MELLITUS; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK FACTOR; DIET; FEMALE; HEALTH BEHAVIOR; HEALTH CARE POLICY; META ANALYSIS (TOPIC); OBESITY; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PREVALENCE;

CHINA; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DIET; FEMALE; HEALTH BEHAVIOR; HEALTH POLICY; HUMANS; LIFE STYLE; MALNUTRITION; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; META-ANALYSIS AS TOPIC; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; PUBLIC HEALTH; RISK FACTORS;

EID: 85017108696     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2017.48     Document Type: Review

References (138)

1. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet 2010; 375: 408-418.
2. Nanditha A, Ma RC, Ramachandran A, Snehalatha C, Chan JC, Chia KS et al. Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes Care 2016; 39: 472-485.
3. Xu Y, Wang L, He J, Bi Y, Li M, Wang T et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013; 310: 948-959.
4. Chan JC, Zhang Y, Ning G. Diabetes in China: a societal solution for a personal challenge. Lancet Diabetes Endocrinol 2014; 2: 969-979.
5. Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol 2014; 2: 935-943.
6. Chan JC, Lau ES, Luk AO, Cheung KK, Kong AP, Yu LW et al. Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis. Am J Med 2014; 127: 616-624.
7. Huo X, Gao L, Guo L, Xu W, Wang W, Zhi X et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a crosssectional study. Lancet Diabetes Endocrinol 2016; 4: 115-124.
8. Zheng Y, Ji L, Ling W. Cost-of-illness studies of diabetes mellitus in China: a systematic review. Chin J Endocrinol Metab 2012; 28: 821-825.
9. Wang W, McGreevey WP, Fu C, Zhan S, Luan R, Chen W et al. Type 2 diabetes mellitus in China: a preventable economic burden. Am J Manag Care 2009; 15: 593-601.
10. Lu J, Wang L, Li M, Xu Y, Jiang Y, Wang W et al. Metabolic syndrome among adults in China-The 2010 China Noncommunicable Disease Surveillance. J Clin Endocrinol Metab 2016; e-pub ahead of print 29 November 2016.
11. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011; 34: 1249-1257.
12. Ma RC, Lin X, Jia W. Causes of type 2 diabetes in China. Lancet Diabetes Endocrinol 2014; 2: 12.
13. Popkin BM. Synthesis and implications: China's nutrition transition in the context of changes across other low-and middle-income countries. Obes Rev 2014; 15(Suppl 1): 60-67.
14. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2013; 381: 1987-2015.
15. Wang H, Zhai F. Programme and policy options for preventing obesity in China. Obes Rev 2013; 14(Suppl 2): 134-140.
16. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and earlylife conditions on adult health and disease. N Engl J Med 2008; 359: 61-73.
17. Godfrey KM, Gluckman PD, Hanson MA. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metab 2010; 21: 199-205.
18. Berends LM, Ozanne SE. Early determinants of type-2 diabetes. Best Pract Res Clin Endocrinol Metab 2012; 26: 569-580.
19. Hanson MA, Gluckman PD. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev 2014; 94: 1027-1076.
20. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991; 303: 1019-1022.
21. Barker DJP, Hales CN, Fall CD, Osmond C, Phipps K, Clark P. Type 2 (non-insulindependent) diabetes mellitus, hypertension, and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-67.
22. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 2008; 300: 2886-2897.
23. Wei JN, Sung FC, Li CY, Chang CH, Lin RS, Lin CC et al. Low birth weight and high birth weight infants are both at an increased risk to have type 2 diabetes among schoolchildren in Taiwan. Diabetes Care 2003; 26: 343-348.
24. Chen Y, Li G, Ruan Y, Zou L, Wang X, Zhang W. An epidemiological survey on low birth weight infants in China and analysis of outcomes of full-term low birth weight infants. BMC Pregnancy Childbirth 2013; 13: 242.
25. Shan X, Chen F, Wang W, Zhao J, Teng Y, Wu M et al. Secular trends of low birthweight and macrosomia and related maternal factors in Beijing, China: a longitudinal trend analysis. BMC Pregnancy Childbirth 2014; 14: 105.
26. Li G, Kong L, Li Z, Zhang L, Fan L, Zou L et al. Prevalence of macrosomia and its risk factors in China: a multicentre survey based on birth data involving 101 723 singleton term infants. Paediatr Perinat Epidemiol 2014; 28: 345-350.
27. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85: 571-633.
28. Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998; 351: 173-177.
29. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Int J Epidemiol 2013; 42: 1215-1222.
30. Smil V. China's great famine: 40 years later. BMJ 1999; 319: 1619-1621.
31. Li Y, He Y, Qi L, Jaddoe VW, Feskens EJ, Yang X et al. Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood. Diabetes 2010; 59: 2400-2406.
32. Wang N, Wang X, Han B, Li Q, Chen Y, Zhu C et al. Is exposure to famine in childhood and economic development in adulthood associated with diabetes? J Clin Endocrinol Metab 2015; 100: 4514-4523.
33. Li J, Liu S, Li S, Feng R, Na L, Chu X et al. Prenatal exposure to famine and the development of hyperglycemia and type 2 diabetes in adulthood across consecutive generations: a population-based cohort study of families in Suihua, China. Am J Clin Nutr 2017; 105: 221-227.
34. Liu L, Wang W, Sun J, Pang Z. Association of famine exposure during early life with the risk of type 2 diabetes in adulthood: a meta-analysis. Eur J Nutr 2016; e-pub ahead of print 20 December 2016; doi:10.1007/s00394-016-1363-1.
35. Ma RC, Chan JC, Tam WH, Hanson MA, Gluckman PD. Gestational diabetes, maternal obesity, and the NCD burden. Clin Obstet Gynecol 2013; 56: 633-641.
36. International Diabetes Federation. IDF Diabetes Atlas, 7th edn. The International Diabetes Federation: Brussels, Belgium, 2015.
37. Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes 1988; 37: 622-628.
38. Ma RC, Chan JC. Pregnancy and diabetes scenario around the world: China. Int J Gynaecol Obstet 2009; 104(Suppl 1): S42-S45.
39. Ma RC, Tutino GE, Lillycrop KA, Hanson MA, Tam WH. Maternal diabetes, gestational diabetes and the role of epigenetics in their long term effects on offspring. Prog Biophys Mol Biol 2015; 118: 55-68.
40. Tam CH, Wang Y, Luan J, Lee HM, Luk AO, Tutino GE et al. Maternal history of diabetes is associated with increased cardiometabolic risk in Chinese. Nutr Diabetes 2014; 4: e112.
41. Zhang F, Dong L, Zhang CP, Li B, Wen J, Gao W et al. Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabet Med 2011; 28: 652-657.
42. Leng J, Shao P, Zhang C, Tian H, Zhang F, Zhang S et al. Prevalence of gestational diabetes mellitus and its risk factors in Chinese pregnant women: a prospective population-based study in Tianjin, China. PLoS One 2015; 10: e0121029.
43. Zhu WW, Yang HX, Wei YM, Yan J, Wang ZL, Li XL et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care 2013; 36: 586-590.
44. Tam WH, Ma RC, Yang X, Ko GT, Tong PC, Cockram CS et al. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero. Pediatrics 2008; 122: 1229-1234.
45. Tam WH, Ma RC, Ozaki R, Li AM, Chan MHM, Yuen LY et al. In utero exposure to maternal hyperglycemia increases children's cardiometabolic risk. Diabetes Care 2017; e-pub ahead of print 9 March 2017; doi:10.2337/dc16-2397.
46. Shi P, Yang W, Yu Q, Zhao Q, Li C, Ma X et al. Overweight, gestational weight gain and elevated fasting plasma glucose and their association with macrosomia in Chinese pregnant women. Matern Child Health J 2014; 18: 10-15.
47. Institute of Medicine (IOM) and National Research Council (NRC). Weight Gain During Pregnancy: Reexamining the Guidelines, The National Academies Collection: Reports funded by National Institutes of Health. National Academies Press: Washington, DC, USA, 2009.
48. Tam CHT, Ozaki R, So WY, Chan JCN, Song X, Tam WH et al. Gestational weight gain is associated with short and long-term child health outcomes in Chinese: an analysis using structural equation modeling. World Diabetes Congress 2015: Vancouver, Canada, 2015.
49. Hochner H, Friedlander Y, Calderon-Margalit R, Meiner V, Sagy Y, Avgil-Tsadok M et al. Associations of maternal prepregnancy body mass index and gestational weight gain with adult offspring cardiometabolic risk factors: the Jerusalem Perinatal Family Follow-up Study. Circulation 2012; 125: 1381-1389.
50. Masuyama H, Hiramatsu Y. Effects of a high-fat diet exposure in utero on the metabolic syndrome-like phenomenon in mouse offspring through epigenetic changes in adipocytokine gene expression. Endocrinology 2012; 153: 2823-2830.
51. Crume TL, Brinton JT, Shapiro A, Kaar J, Glueck DH, Siega-Riz AM et al. Maternal dietary intake during pregnancy and offspring body composition: The Healthy Start Study. Am J Obstet Gynecol 2016; 215: 609 e1-609 e8.
52. Shapiro AL, Kaar JL, Crume TL, Starling AP, Siega-Riz AM, Ringham BM et al. Maternal diet quality in pregnancy and neonatal adiposity: the Healthy Start Study. Int J Obes 2016; 40: 1056-1062.
53. Hanson MA, Bardsley A, De-Regil LM, Moore SE, Poston L, Ma RC et al. FIGO recommendation on adolescent, preconception and maternal nutrition: think nutrition first. Int J Gynaecol Obstet 2015; 131(Suppl 4): S213-S253. in press.
54. Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008; 51: 29-38.
55. Finer S, Saravanan P, Hitman G, Yajnik C. The role of the one-carbon cycle in the developmental origins of type 2 diabetes and obesity. Diabet Med 2014; 31: 263-272.
56. Liu N, Mao L, Sun X, Liu L, Chen B, Ding Q. Postpartum practices of puerperal women and their influencing factors in three regions of Hubei, China. BMC Public Health 2006; 6: 274.
57. Chan SM, Nelson EA, Leung SS, Cheung PC, Li CY. Special postpartum dietary practices of Hong Kong Chinese women. Eur J Clin Nutr 2000; 54: 797-802.
58. Jaddoe VW, de Jonge LL, van Dam RM, Willett WC, Harris H, Stampfer MJ et al. Fetal exposure to parental smoking and the risk of type 2 diabetes in adult women. Diabetes Care 2014; 37: 2966-2973.
59. Gardebjer EM, Anderson ST, Pantaleon M, Wlodek ME, Moritz KM. Maternal alcohol intake around the time of conception causes glucose intolerance and insulin insensitivity in rat offspring, which is exacerbated by a postnatal highfat diet. FASEB J 2015; 29: 2690-2701.
60. Voerman E, Jaddoe VW, Gishti O, Hofman A, Franco OH, Gaillard R. Maternal caffeine intake during pregnancy, early growth, and body fat distribution at school age. Obesity (Silver Spring) 2016; 24: 1170-1177.
61. Thayer ZM, Feranil AB, Kuzawa CW. Maternal cortisol disproportionately impacts fetal growth in male offspring: evidence from the Philippines. Am J Hum Biol 2012; 24: 1-4.
62. Long Q, Klemetti R, Wang Y, Tao F, Yan H, Hemminki E. High caesarean section rate in rural China: is it related to health insurance (New Co-operative Medical Scheme)? Soc Sci Med 2012; 75: 733-737.
63. Yang X, Li Y, Li C, Zhang W. Current overview of pregnancy complications and live-birth outcome of assisted reproductive technology in mainland China. Fertil Steril 2014; 101: 385-391.
64. Dominguez-Bello MG, De Jesus-Laboy KM, Shen N, Cox LM, Amir A, Gonzalez A et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 2016; 22: 250-253.
65. Freeman E, Fletcher R, Collins CE, Morgan PJ, Burrows T, Callister R. Preventing and treating childhood obesity: time to target fathers. Int J Obes 2012; 36: 12-15.
66. Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, Morris MJ. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 2010; 467: 963-966.
67. Donkin I, Versteyhe S, Ingerslev LR, Qian K, Mechta M, Nordkap L et al. Obesity and bariatric surgery drive epigenetic variation of spermatozoa in humans. Cell Metab 2016; 23: 369-378.
68. Ziegler AG, Wallner M, Kaiser I, Rossbauer M, Harsunen MH, Lachmann L et al. Long-term protective effect of lactation on the development of type 2 diabetes in women with recent gestational diabetes mellitus. Diabetes 2012; 61: 3167-3171.
69. Gunderson EP, Hurston SR, Ning X, Lo JC, Crites Y, Walton D et al. Lactation and progression to type 2 diabetes mellitus after gestational diabetes mellitus: a Prospective Cohort Study. Ann Intern Med 2015; 163: 889-898.
70. Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB. Duration of lactation and incidence of type 2 diabetes. JAMA 2005; 294: 2601-2610.
71. Gunderson EP, Kim C, Quesenberry Jr CP, Marcovina S, Walton D, Azevedo RA et al. Lactation intensity and fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin in postpartum women with recent gestational diabetes mellitus: the SWIFT cohort. Metabolism 2014; 63: 941-950.
72. Yan J, Liu L, Zhu Y, Huang G, Wang PP. The association between breastfeeding and childhood obesity: a meta-analysis. BMC Public Health 2014; 14: 1267.
73. Dewey KG, Heinig MJ, Nommsen LA, Peerson JM, Lonnerdal B. Breast-fed infants are leaner than formula-fed infants at 1 y of age: the DARLING study. Am J Clin Nutr 1993; 57: 140-145.
74. Dewey KG, Heinig MJ, Nommsen LA, Peerson JM, Lonnerdal B. Growth of breastfed and formula-fed infants from 0 to 18 months: the DARLING Study. Pediatrics 1992; 89(6 Pt 1): 1035-1041.
75. Jingxiong J, Rosenqvist U, Huishan W, Koletzko B, Guangli L, Jing H et al. Relationship of parental characteristics and feeding practices to overweight in infants and young children in Beijing, China. Public Health Nutr 2009; 12: 973-978.
76. Mei H, Guo B, Yin B, Liang X, Adair L, Thompson A et al. Interactive effects of early exclusive breastfeeding and pre-pregnancy maternal weight status on young children's BMI-A Chinese Birth Cohort. PLoS One 2015; 10: e0144357.
77. Crowther NJ, Cameron N, Trusler J, Gray IP. Association between poor glucose tolerance and rapid post natal weight gain in seven-year-old children. Diabetologia 1998; 41: 1163-1167.
78. Yang Z, Lai J, Yu D, Duan Y, Pang X, Jiang S et al. Breastfeeding rates in China: a cross-sectional survey and estimate of benefits of improvement. Lancet 2016; 388(Suppl 1): S47.
79. Tang L, Lee AH, Binns CW, Yang Y, Wu Y, Li Y et al. Widespread usage of infant formula in China: a major public health problem. Birth 2014; 41: 339-343.
80. Wadsworth M, Butterworth S, Marmot M, Ecob R, Hardy R. Early growth and type 2 diabetes: evidence from the 1946 British Birth Cohort. Diabetologia 2005; 48: 2505-2510.
81. Yu Z, Han S, Chu J, Xu Z, Zhu C, Guo X. Trends in overweight and obesity among children and adolescents in China from 1981 to 2010: a meta-analysis. PLoS One 2012; 7: e51949.
82. Song Y, Wang HJ, Ma J, Wang Z. Secular trends of obesity prevalence in urban Chinese children from 1985 to 2010: gender disparity. PLoS One 2013; 8: e53069.
83. Gillman MW, Ludwig DS. How early should obesity prevention start? N Engl J Med 2013; 369: 2173-2175.
84. Popkin BM, Hawkes C. Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses. Lancet Diabetes Endocrinol 2016; 4: 174-186.
85. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004; 292: 927-934.
86. Ma W, Ma G, Hu X. The beverage consumption practice of Chinese children in four urban areas. Chin J School Health 2011; 22: 102-104.
87. Shang XW, Liu AL, Zhang Q, Hu XQ, Du SM, Ma J et al. Report on childhood obesity in China (9): sugar-sweetened beverages consumption and obesity. Biomed Environ Sci 2012; 25: 125-132.
88. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009; 32: 1278-1283.
89. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes 2013; 37: 16-23.
90. Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012; 488: 621-626.
91. Legler J, Fletcher T, Govarts E, Porta M, Blumberg B, Heindel JJ et al. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab 2015; 100: 1278-1288.
92. Sun Q, Yue P, Deiuliis JA, Lumeng CN, Kampfrath T, Mikolaj MB et al. Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. Circulation 2009; 119: 538-546.
93. O'Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA et al. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation 2005; 111: 2913-2920.
94. Wei Y, Zhang JJ, Li Z, Gow A, Chung KF, Hu M et al. Chronic exposure to air pollution particles increases the risk of obesity and metabolic syndrome: findings from a natural experiment in Beijing. FASEB J 2016; 30: 2115-2122.
95. Li M, Xu Y, Xu M, Ma L, Wang T, Liu Y et al. Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab 2012; 97: 2033-2038.
96. Crews D, McLachlan JA. Epigenetics, evolution, endocrine disruption, health, and disease. Endocrinology 2006; 147(6 Suppl): S4-10.
97. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009; 30: 293-342.
98. Song Y, Chou EL, Baecker A, You NC, Song Y, Sun Q et al. Endocrine-disrupting chemicals, risk of type 2 diabetes, and diabetes-related metabolic traits: a systematic review and meta-analysis. J Diabetes 2016; 8: 516-532.
99. Wang T, Li M, Chen B, Xu M, Xu Y, Huang Y et al. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab 2012; 97: E223-E227.
100. Li DK, Miao M, Zhou Z, Wu C, Shi H, Liu X et al. Urine bisphenol-A level in relation to obesity and overweight in school-age children. PLoS One 2013; 8: e65399.
101. Casals-Casas C, Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 2011; 73: 135-162.
102. Batista TM, Alonso-Magdalena P, Vieira E, Amaral ME, Cederroth CR, Nef S et al. Short-term treatment with bisphenol-A leads to metabolic abnormalities in adult male mice. PLoS One 2012; 7: e33814.
103. Alonso-Magdalena P, Ropero AB, Carrera MP, Cederroth CR, Baquie M, Gauthier BR et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 2008; 3: e2069.
104. Kurita H, Yoshioka W, Nishimura N, Kubota N, Kadowaki T, Tohyama C. Aryl hydrocarbon receptor-mediated effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on glucose-stimulated insulin secretion in mice. J Appl Toxicol 2009; 29: 689-694.
105. Li F, Liu Y, Lu J, Liang L, Harmer P. Ambient air pollution in China poses a multifaceted health threat to outdoor physical activity. J Epidemiol Community Health 2015; 69: 201-204.
106. Desvergne B, Feige JN, Casals-Casas C. PPAR-mediated activity of phthalates: a link to the obesity epidemic? Mol Cell Endocrinol 2009; 304: 43-48.
107. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007; 99: 366-394.
108. Zhao YG, Wong CK, Wong MH. Environmental contamination, human exposure and body loadings of perfluorooctane sulfonate (PFOS), focusing on Asian countries. Chemosphere 2012; 89: 355-368.
109. Zhang H, Shi Z, Liu Y, Wei Y, Dai J. Lipid homeostasis and oxidative stress in the liver of male rats exposed to perfluorododecanoic acid. Toxicol Appl Pharmacol 2008; 227: 16-25.
110. Xu J, Shimpi P, Armstrong L, Salter D, Slitt AL. PFOS induces adipogenesis and glucose uptake in association with activation of Nrf2 signaling pathway. Toxicol Appl Pharmacol 2016; 290: 21-30.
111. Lin Y, Wei J, Li Y, Chen J, Zhou Z, Song L et al. Developmental exposure to di(2-ethylhexyl) phthalate impairs endocrine pancreas and leads to long-term adverse effects on glucose homeostasis in the rat. Am J Physiol Endocrinol Metab 2011; 301: E527-E538.
112. Slomko H, Heo HJ, Einstein FH. Minireview: epigenetics of obesity and diabetes in humans. Endocrinology 2012; 153: 1025-1030.
113. Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes 2011; 60: 1528-1534.
114. Kucharski R, Maleszka J, Foret S, Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science 2008; 319: 1827-1830.
115. Asencot M, Lensky Y. The effect of sugars and juvenile hormone on the differentiation of the female honeybee larvae (Apis mellifera L.) to queens. Life Sci 1976; 18: 693-699.
116. Buttstedt A, Ihling CH, Pietzsch M, Moritz RF. Royalactin is not a royal making of a queen. Nature 2016; 537: E10-E12.
117. Lillycrop KA, Rodford J, Garratt ES, Slater-Jefferies JL, Godfrey KM, Gluckman PD et al. Maternal protein restriction with or without folic acid supplementation during pregnancy alters the hepatic transcriptome in adult male rats. Br J Nutr 2010; 103: 1711-1719.
118. Lillycrop KA, Burdge GC. Maternal diet as a modifier of offspring epigenetics. J Dev Orig Health Dis 2015; 6: 88-95.
119. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 2008; 105: 17046-17049.
120. Clarke-Harris R, Wilkin TJ, Hosking J, Pinkney J, Jeffery AN, Metcalf BS et al. PGC1alpha promoter methylation in blood at 5-7 years predicts adiposity from 9 to 14 years (EarlyBird 50). Diabetes 2014; 63: 2528-2537.
121. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55-60.
122. Cox LM, Blaser MJ. Pathways in microbe-induced obesity. Cell Metab 2013; 17: 883-894.
123. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
124. Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014; 514: 181-186.
125. Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013; 498: 99-103.
126. World Health Organization. Report of the Commission on Ending Childhood Obesity. World Health Organization 2016: Geneva, Switzerland, 2015.
127. The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition (Chinese translated version). Chin J Perinat Med 2016; 1912: 960-963.
128. Sustainable Development Goals-17 Goals to Transform our World. United Nations, New York, NY, USA, 2015. Available from: http://www.un.org/sustaina bledevelopment/sustainable-development-goals/.
129. Persson LA. Prenatal nutrition, socioenvironmental conditions, and child development. Lancet Glob Health 2017; 5: e127-e128.
130. Colchero MA, Popkin BM, Rivera JA, Ng SW. Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study. BMJ 2016; 352: h6704.
131. Hanson M, Barker M, Dodd JM, Kumanyika S, Norris S, Steegers E et al. Interventions to prevent maternal obesity before conception, during pregnancy, and post partum. Lancet Diabetes Endocrinol 2017; 5: 65-76.
132. Simmons D, van Poppel MN. UPBEAT, RADIEL, and DALI: what's the difference? Lancet Diabetes Endocrinol 2015; 3: 761.
133. Song C, Li J, Leng J, Ma RC, Yang X. Lifestyle intervention can reduce the risk of gestational diabetes: a meta-analysis of randomized controlled trials. Obes Rev 2016; 17: 960-969.
134. Catalano P, deMouzon SH. Maternal obesity and metabolic risk to the offspring: why lifestyle interventions may have not achieved the desired outcomes. Int J Obes 2015; 39: 642-649.
135. Yan J, Yang H. Gestational diabetes in China: challenges and coping strategies. Lancet Diabetes Endocrinol 2014; 2: 930-931.
136. Chinese Centre for Disease Control and Prevention (China CDC). China National Plan for NCD Prevention and Treatment, 2012-2015. Available from: http://www. chinacdc.cn/en/ne/201207/t20120725-64430.html (accessed 10 February 2017).
137. Gordon-Larsen P, Wang H, Popkin BM. Overweight dynamics in Chinese children and adults. Obes Rev 2014; 15(Suppl 1): 37-48.
138. Lu Y, Zhang J, Lu X, Xi W, Li Z. Secular trends of macrosomia in southeast China, 1994-2005. BMC Public Health 2011; 11: 818.